MedPath

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

Completed
Conditions
Diabetic Retinopathy
Registration Number
NCT02876744
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long term, a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy. The accuracy of the analysis of the vascularization of retinal layers of the posterior pole of the eye by the OCT-A , will detect, early and in a quantifiable manner, whether or not there are areas of macular ischemia in a patient. However, current technical limitations (small field analysis) of OCT-A imaging only allow a limited study of retina at the posterior pole of the fundus.

This study seeks to demonstrate whether there is a link between macular ischemia detected by the OCT-A and peripheral retinal ischemia detected by the fluorescein angiographies, in diabetic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • diabetes type I or type II
  • follow-up with fluorescein angiography
Exclusion Criteria
  • known allergy to fluorescein
  • contra-indication to fluorescein angiography
  • pregnant or breast-feeding patient
  • technical impossibility to analyse retinal ischemic areas on fluorescein angiography or OCT-A.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection and measure of ischemic territories in central and peripheral retinaimmediate
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation Opthalmologique A de Rothschild

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath